Global Cancer Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Cancer Drugs

• 1.1 Definition of Cancer Drugs
• 1.2 Cancer Drugs Segment by Type
  • 1.2.1 Global Cancer Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Breast Cancer
  • 1.2.3 Blood Cancer
  • 1.2.4 Gastrointestinal Cancer
  • 1.2.5 Prostate Cancer
  • 1.2.6 Skin Cancer
  • 1.2.7 Lung Cancer
  • 1.2.8 Others
• 1.3 Cancer Drugs Segment by Applications
  • 1.3.1 Global Cancer Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Immunotherapy
  • 1.3.3 Targeted Therapy
  • 1.3.4 Chemotherapy
  • 1.3.5 Hormone Therapy
  • 1.3.6 Others
• 1.4 Global Cancer Drugs Overall Market
  • 1.4.1 Global Cancer Drugs Revenue (2014-2025)
  • 1.4.2 Global Cancer Drugs Production (2014-2025)
  • 1.4.3 North America Cancer Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Cancer Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Cancer Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Cancer Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Cancer Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Cancer Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Cancer Drugs
• 2.3 Manufacturing Process Analysis of Cancer Drugs
• 2.4 Industry Chain Structure of Cancer Drugs

3 Development and Manufacturing Plants Analysis of Cancer Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Cancer Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Cancer Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Cancer Drugs Production and Capacity Analysis
• 4.2 Cancer Drugs Revenue Analysis
• 4.3 Cancer Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Cancer Drugs Regional Market Analysis

• 5.1 Cancer Drugs Production by Regions
  • 5.1.1 Global Cancer Drugs Production by Regions
  • 5.1.2 Global Cancer Drugs Revenue by Regions
• 5.2 Cancer Drugs Consumption by Regions
• 5.3 North America Cancer Drugs Market Analysis
  • 5.3.1 North America Cancer Drugs Production
  • 5.3.2 North America Cancer Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Cancer Drugs Import and Export
• 5.4 Europe Cancer Drugs Market Analysis
  • 5.4.1 Europe Cancer Drugs Production
  • 5.4.2 Europe Cancer Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Cancer Drugs Import and Export
• 5.5 China Cancer Drugs Market Analysis
  • 5.5.1 China Cancer Drugs Production
  • 5.5.2 China Cancer Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Cancer Drugs Import and Export
• 5.6 Japan Cancer Drugs Market Analysis
  • 5.6.1 Japan Cancer Drugs Production
  • 5.6.2 Japan Cancer Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Cancer Drugs Import and Export
• 5.7 Southeast Asia Cancer Drugs Market Analysis
  • 5.7.1 Southeast Asia Cancer Drugs Production
  • 5.7.2 Southeast Asia Cancer Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Cancer Drugs Import and Export
• 5.8 India Cancer Drugs Market Analysis
  • 5.8.1 India Cancer Drugs Production
  • 5.8.2 India Cancer Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Cancer Drugs Import and Export

6 Cancer Drugs Segment Market Analysis (by Type)

• 6.1 Global Cancer Drugs Production by Type
• 6.2 Global Cancer Drugs Revenue by Type
• 6.3 Cancer Drugs Price by Type

7 Cancer Drugs Segment Market Analysis (by Application)

• 7.1 Global Cancer Drugs Consumption by Application
• 7.2 Global Cancer Drugs Consumption Market Share by Application (2014-2019)

8 Cancer Drugs Major Manufacturers Analysis

• 8.1 Bayer
  • 8.1.1 Bayer Cancer Drugs Production Sites and Area Served
  • 8.1.2 Bayer Product Introduction, Application and Specification
  • 8.1.3 Bayer Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 GlaxoSmithKline
  • 8.2.1 GlaxoSmithKline Cancer Drugs Production Sites and Area Served
  • 8.2.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.2.3 GlaxoSmithKline Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Novartis
  • 8.3.1 Novartis Cancer Drugs Production Sites and Area Served
  • 8.3.2 Novartis Product Introduction, Application and Specification
  • 8.3.3 Novartis Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Sanofi and Pfizer
  • 8.4.1 Sanofi and Pfizer Cancer Drugs Production Sites and Area Served
  • 8.4.2 Sanofi and Pfizer Product Introduction, Application and Specification
  • 8.4.3 Sanofi and Pfizer Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Amgen
  • 8.5.1 Amgen Cancer Drugs Production Sites and Area Served
  • 8.5.2 Amgen Product Introduction, Application and Specification
  • 8.5.3 Amgen Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Merck
  • 8.6.1 Merck Cancer Drugs Production Sites and Area Served
  • 8.6.2 Merck Product Introduction, Application and Specification
  • 8.6.3 Merck Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Bristol-Myers Squibb
  • 8.7.1 Bristol-Myers Squibb Cancer Drugs Production Sites and Area Served
  • 8.7.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.7.3 Bristol-Myers Squibb Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Celgene Corporation
  • 8.8.1 Celgene Corporation Cancer Drugs Production Sites and Area Served
  • 8.8.2 Celgene Corporation Product Introduction, Application and Specification
  • 8.8.3 Celgene Corporation Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Ariad Pharmaceuticals
  • 8.9.1 Ariad Pharmaceuticals Cancer Drugs Production Sites and Area Served
  • 8.9.2 Ariad Pharmaceuticals Product Introduction, Application and Specification
  • 8.9.3 Ariad Pharmaceuticals Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Eli Lilly
  • 8.10.1 Eli Lilly Cancer Drugs Production Sites and Area Served
  • 8.10.2 Eli Lilly Product Introduction, Application and Specification
  • 8.10.3 Eli Lilly Cancer Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Hoffmann-La Roche
• 8.12 Boehringer Ingelheim
• 8.13 Johnson and Johnson
• 8.14 Teva Pharmaceuticals

9 Development Trend of Analysis of Cancer Drugs Market

• 9.1 Global Cancer Drugs Market Trend Analysis
  • 9.1.1 Global Cancer Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Cancer Drugs Regional Market Trend
  • 9.2.1 North America Cancer Drugs Forecast 2019-2025
  • 9.2.2 Europe Cancer Drugs Forecast 2019-2025
  • 9.2.3 China Cancer Drugs Forecast 2019-2025
  • 9.2.4 Japan Cancer Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Cancer Drugs Forecast 2019-2025
  • 9.2.6 India Cancer Drugs Forecast 2019-2025
• 9.3 Cancer Drugs Market Trend (Product Type)
• 9.4 Cancer Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Cancer Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List